Neurogene (NGNE) Retained Earnings (2018 - 2025)

Historic Retained Earnings for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to -$327.9 million.

  • Neurogene's Retained Earnings fell 3505.52% to -$327.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$327.9 million, marking a year-over-year decrease of 3505.52%. This contributed to the annual value of -$262.3 million for FY2024, which is 4015.09% down from last year.
  • Per Neurogene's latest filing, its Retained Earnings stood at -$327.9 million for Q3 2025, which was down 3505.52% from -$307.0 million recorded in Q2 2025.
  • Neurogene's Retained Earnings' 5-year high stood at -$187.2 million during Q4 2023, with a 5-year trough of -$471.9 million in Q3 2023.
  • For the 3-year period, Neurogene's Retained Earnings averaged around -$313.0 million, with its median value being -$284.9 million (2025).
  • The largest annual percentage gain for Neurogene's Retained Earnings in the last 5 years was 5613.2% (2024), contrasted with its biggest fall of 4015.09% (2024).
  • Quarter analysis of 3 years shows Neurogene's Retained Earnings stood at -$187.2 million in 2023, then tumbled by 40.15% to -$262.3 million in 2024, then dropped by 25.02% to -$327.9 million in 2025.
  • Its Retained Earnings was -$327.9 million in Q3 2025, compared to -$307.0 million in Q2 2025 and -$284.9 million in Q1 2025.